Bcl-3 is an atypical member of the inhibitor of NF-kappa B family of proteins since it can function as a coactivator of transcription. Although this oncogene was described in leukemia, it is overexpressed in a number of solid tumors as well. The oncogenic potential of Bcl-3 has been associated with its capacity to increase proliferation by means of activating the cyclin D1 promoter and to its antiapoptotic role mediated by the inhibiton of p53 activity. In the course of dissecting these properties, we found that depleting Bcl-3 protein using shRNAs induce a decrease of proliferation and clonogenic survival associated with the induction of multinucleation and increased ploidy. These effects were associated with a DNA damage response, a delay in G2/M checkpoint and the induction of centrosome amplification © 2010 Zamora et al; licensee BioMed Central Ltd.
CITATION STYLE
Zamora, R., Espinosa, M., Ceballos-Cancino, G., Segura, B., Maldonado, V., & Melendez-Zajgla, J. (2010). Depletion of the oncoprotein Bcl-3 induces centrosome amplification and aneuploidy in cancer cells. Molecular Cancer, 9. https://doi.org/10.1186/1476-4598-9-223
Mendeley helps you to discover research relevant for your work.